Doctor Patrick Moriarty
University of Kansas Medical Center, Kansas City (United States of America)
Follow
Biography
Professor of Medicine, The University of Kansas Medical Center in Kansas City, Kansas. Director of Clinical Pharmacology and the Atherosclerosis & Lipid-Apheresis Center. Doctorate in Medicine and Surgery at the University of Rome School of Medicine and Surgery in Italy. Residency in Internal Medicine and training in Clinical Pharmacology at the University of Kansas Medical Center. A fellow of the American College of Physicians, the American College of Cardiology, the European Society of Cardiology, and the National Lipid Association. He was the 2014-2015 president of the International Society for Apheresis. He reviews manuscripts for multiple scientific journals and is the associate editor for the Journal of Clinical Apheresis. Published over 150 peer-reviewed articles/chapters. His research activities include atherosclerosis, familial hypercholesterolemia, Lp(a), Lipid-apheresis, inflammation, dementia, and hemorhelogy. Operates the largest U.S. Lipid-apheresis program.
Contributor content
Presentation
Red cell distribution width as a predictor of cardiovascular events in high-risk patients with statin intolerance: post-hoc analysis of the CLEAR Outcomes trial
Presentation
Presentation
Efficacy and Safety of Evolocumab Compared With Continued Lipoprotein Apheresis: Results of a Randomised, Controlled, Open-Label Study
Presentation
ESCAPE - Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trial
Presentation
